Induced IL-17-Producing Γδt Cells Play a Protective Role in Intestinal Graft-Versus-Host Disease

L. Xu,H. Huang
DOI: https://doi.org/10.1182/blood-2018-99-119161
IF: 20.3
2018-01-01
Blood
Abstract:Acute graft-versus-host disease (aGVHD) is one of the lethal complications after allogeneic stem cell transplantation (allo-SCT). Intestine, as the major target organ of aGVHD, has a significant morbidity and mortality. T-cell-derived interleukin-17A (IL-17A) can mediate immunopathology in GVHD. According to a recent study in murine SCT models, the recipients who lack IL-17 would develop intestinal hyper-acute GVHD. Our previous study demonstrated that γδT17 cells were the main source of IL-17 in intestinal aGVHD. These findings suggest that γδT17 cells may have the capacity to attenuate intestinal aGVHD and have the potential for prognosis prediction. However, primary γδT17 cells account for only 0.1% of mice splenocytes, which makes it difficult to obtain a sufficient number of cells. To explore the function of γδT17 cells in aGVHD, we improved an in vitro induction protocol to generate large numbers of purified activated γδT17 cells. Then we performed survival studies in a murine allo-SCT model. We observed that co-infusion of induced γδT17 cells reduced aGVHD and increased recipient survival.
What problem does this paper attempt to address?